These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15567302)

  • 1. Non-phospholipid vesicles for pulmonary glucocorticoid delivery.
    Terzano C; Allegra L; Alhaique F; Marianecci C; Carafa M
    Eur J Pharm Biopharm; 2005 Jan; 59(1):57-62. PubMed ID: 15567302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
    Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
    J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis.
    Chimote G; Banerjee R
    J Biomed Mater Res A; 2009 May; 89(2):281-92. PubMed ID: 18431766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M; Bosse S; Oltmanns U; Schumacher A; Witt C
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants.
    Ita KB; Du Preez J; Lane ME; Hadgraft J; du Plessis J
    J Pharm Pharmacol; 2007 Sep; 59(9):1215-22. PubMed ID: 17883892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases.
    De Leo V; Ruscigno S; Trapani A; Di Gioia S; Milano F; Mandracchia D; Comparelli R; Castellani S; Agostiano A; Trapani G; Catucci L; Conese M
    Int J Pharm; 2018 Jul; 545(1-2):378-388. PubMed ID: 29678545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.
    Qi A; Friend JR; Yeo LY; Morton DA; McIntosh MP; Spiccia L
    Lab Chip; 2009 Aug; 9(15):2184-93. PubMed ID: 19606295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the co-loading of lidocaine chemical forms in surfactant/phospholipid vesicles for improved skin delivery.
    Caddeo C; Valenti D; Nácher A; Manconi M; Fadda AM
    J Pharm Pharmacol; 2015 Jul; 67(7):909-17. PubMed ID: 25648182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.
    Onoue S; Yamada S; Yajima T
    Peptides; 2007 Sep; 28(9):1640-50. PubMed ID: 17537541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids.
    Hübner M; Hochhaus G; Derendorf H
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):469-88. PubMed ID: 16054538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-coated liposomes for delivery to lungs by nebulisation.
    Zaru M; Manca ML; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction.
    Carafa M; Di Marzio L; Marianecci C; Cinque B; Lucania G; Kajiwara K; Cifone MG; Santucci E
    Eur J Pharm Sci; 2006 Aug; 28(5):385-93. PubMed ID: 16797946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model.
    Freiwald M; Valotis A; Kirschbaum A; McClellan M; Mürdter T; Fritz P; Friedel G; Thomas M; Högger P
    Respir Res; 2005 Feb; 6(1):21. PubMed ID: 15727687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.
    Tayab ZR; Hochhaus G
    Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.